Unknown

Dataset Information

0

Progress of molecular targeted therapies for advanced renal cell carcinoma.


ABSTRACT: Vascular endothelial growth factor (VEGF) plays a crucial role in tumor angiogenesis. VEGF expression in metastatic renal cell carcinoma (mRCC) is mostly regulated by hypoxia, predominantly via the hypoxia-induced factor (HIF)/Von Hippel-Lindau (VHL) pathway. Advances in our knowledge of VEGF role in tumor angiogenesis, growth, and progression have permitted development of new approaches for the treatment of mRCC, including several agents targeting VEGF and VEGF receptors: tyrosine kinase pathway, serine/threonine kinases, ? 5 ? 1-integrin, deacetylase, CD70, mammalian target of rapamycin (mTOR), AKT, and phosphatidylinositol 3'-kinase (PI3K). Starting from sorafenib and sunitinib, several targeted therapies have been approved for mRCC treatment, with a long list of agents in course of evaluation, such as tivozanib, cediranib, and VEGF-Trap. Here we illustrate the main steps of tumor angiogenesis process, defining the pertinent therapeutic targets and the efficacy and toxicity profiles of these new promising agents.

SUBMITTER: Conti A 

PROVIDER: S-EPMC3777192 | biostudies-literature | 2013

REPOSITORIES: biostudies-literature

altmetric image

Publications

Progress of molecular targeted therapies for advanced renal cell carcinoma.

Conti Alessandro A   Santoni Matteo M   Amantini Consuelo C   Burattini Luciano L   Berardi Rossana R   Santoni Giorgio G   Cascinu Stefano S   Muzzonigro Giovanni G  

BioMed research international 20130904


Vascular endothelial growth factor (VEGF) plays a crucial role in tumor angiogenesis. VEGF expression in metastatic renal cell carcinoma (mRCC) is mostly regulated by hypoxia, predominantly via the hypoxia-induced factor (HIF)/Von Hippel-Lindau (VHL) pathway. Advances in our knowledge of VEGF role in tumor angiogenesis, growth, and progression have permitted development of new approaches for the treatment of mRCC, including several agents targeting VEGF and VEGF receptors: tyrosine kinase pathwa  ...[more]

Similar Datasets

| S-EPMC7294379 | biostudies-literature
| S-EPMC2921256 | biostudies-literature
| S-EPMC6825975 | biostudies-literature
| S-EPMC3003336 | biostudies-other
| S-EPMC7738296 | biostudies-literature
| S-EPMC3868201 | biostudies-other
| S-EPMC3488422 | biostudies-literature
| S-EPMC5215367 | biostudies-literature
| S-EPMC6429896 | biostudies-literature
| S-EPMC8317793 | biostudies-literature